Jump to
Christopher Cai is a primary care provider and health policy researcher. He is interested in evaluating health financing reforms and quasi-experimental methods. Current projects include Medicare payment reform, private equity in medicine, and prescription drug policy.
Cai CL, Anderson KE, Kesselheim AS, Rome BN. Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps. JAMA Health Forum. 2026;7(6):e261545. doi:10.1001/jamahealthforum.2026.1545
Cai CL, Bhaskar A, Kesselheim AS, Rome BN. Changes in Medicare Part D Plan Designs After the Inflation Reduction Act. JAMA Intern Med. 2025;185(10):1266–1273. doi:10.1001/jamainternmed.2025.4003
Cai CL, Kesselheim AS, Bhaskar A, Rome BN. Insurer Exits After the Inflation Reduction Act Part D Redesign. JAMA. 2025;334(4):360–362. doi:10.1001/jama.2025.7289
Cai CL, Kesselheim AS, Rome BN. Estimated Savings Under the Medicare High-Value Drug List Model. JAMA Intern Med. 2024;184(11):1390–1392. doi:10.1001/jamainternmed.2024.4846
Cai CL, Kesselheim AS, Rome BN. Trends in Fills, Spending, and Prices of Doxepin for Insomnia. JAMA. 2025;333(11):999–1000. doi:10.1001/jama.2024.27526
Cai, C., & Song, Z. (2023). A policy framework for the growing influence of private equity in health care delivery. JAMA, 329(18), 1545-1546.
Cai, C., & Rome, B. N. (2023). Reforming Pharmacy Benefit Managers-A Review of Bipartisan Legislation. The New England journal of medicine, 389(18), 1640-1643.
Medicare payment reform, private equity in medicine, and prescription drug policy.
American Board of Internal Medicine
Primary Care